No Data
Recce Pharmaceuticals Advances US Army Burn Wound Program and Indonesia Phase 3 Trial in March Quarter | ASX:RCE, OTC:RECEF
Recce Deepens U.S. Army Ties and Expands Global Patent Reach in Q3 FY2026
Recce Pharmaceuticals Says Indonesian Regulator Completes Routine Regulatory Inspection of Phase Three Clinical Trial Site
Recce Pharmaceuticals Options Lapse Trims Potential Share Dilution
Inside Biotech: Recce Pharmaceuticals Advances Late-stage Push in Antibiotic Resistance Fight | ASX:RCE, OTC:RECEF
Recce Pharmaceuticals Secures Brazilian Family 4 Patent For Anti-Infectives